Ghost Tree Capital, LLC Dbv Technologies S.A. Transaction History

Ghost Tree Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$2.33 - $12.98 $1.75 Million - $9.74 Million	-750,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$6.75 - $11.15 $5.06 Million - $8.36 Million	750,000 New	750,000 $8.03 Million
Q2 2019 Aug 14, 2019	SELL	$7.58 - $10.0 $6.44 Million - $8.5 Million	-850,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$5.81 - $9.37 $4.94 Million - $7.96 Million	850,000 New	850,000 $6.55 Million
Q2 2018 Aug 14, 2018	SELL	$18.6 - $24.94 $1.86 Million - $2.49 Million	-100,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$20.86 - $26.6 $4.69 Million - $5.99 Million	-225,000 Reduced 69.23%	100,000 $2.31 Million
Q4 2017 Feb 14, 2018	SELL	$20.9 - $49.36 $2 Million - $4.73 Million	-95,886 Reduced 22.78%	325,000 $8 Million
Q3 2017 Nov 14, 2017	BUY	$39.62 - $46.17 $16.7 Million - $19.4 Million	420,886	420,886 $17.9 Million

253K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $124M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.